234 related articles for article (PubMed ID: 27058144)
1. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
Ding Y; Adachi H; Katsuno M; Sahashi K; Kondo N; Iida M; Tohnai G; Nakatsuji H; Sobue G
Neuroscience; 2016 Jul; 327():20-31. PubMed ID: 27058144
[TBL] [Abstract][Full Text] [Related]
2. Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1.
Lee WS; Al-Ramahi I; Jeong HH; Jang Y; Lin T; Adamski CJ; Lavery LA; Rath S; Richman R; Bondar VV; Alcala E; Revelli JP; Orr HT; Liu Z; Botas J; Zoghbi HY
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35499073
[TBL] [Abstract][Full Text] [Related]
3. Dual targeting of brain region-specific kinases potentiates neurological rescue in Spinocerebellar ataxia type 1.
Lee WS; Lavery L; Rousseaux MWC; Rutledge EB; Jang Y; Wan YW; Wu SR; Kim W; Al-Ramahi I; Rath S; Adamski CJ; Bondar VV; Tewari A; Soleimani S; Mota S; Yalamanchili HK; Orr HT; Liu Z; Botas J; Zoghbi HY
EMBO J; 2021 Apr; 40(7):e106106. PubMed ID: 33709453
[TBL] [Abstract][Full Text] [Related]
4. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
5. Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.
Pérez Ortiz JM; Mollema N; Toker N; Adamski CJ; O'Callaghan B; Duvick L; Friedrich J; Walters MA; Strasser J; Hawkinson JE; Zoghbi HY; Henzler C; Orr HT; Lagalwar S
Neurobiol Dis; 2018 Aug; 116():93-105. PubMed ID: 29758256
[TBL] [Abstract][Full Text] [Related]
6. Ataxin-1 regulates proliferation of hippocampal neural precursors.
Asher M; Johnson A; Zecevic B; Pease D; Cvetanovic M
Neuroscience; 2016 May; 322():54-65. PubMed ID: 26876606
[TBL] [Abstract][Full Text] [Related]
7. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.
Orr HT
Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670
[TBL] [Abstract][Full Text] [Related]
8. Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1).
Sánchez I; Balagué E; Matilla-Dueñas A
Hum Mol Genet; 2016 Sep; 25(18):4021-4040. PubMed ID: 27466200
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Strategies for Spinocerebellar Ataxia Type 1.
Kerkhof LMC; van de Warrenburg BPC; van Roon-Mom WMC; Buijsen RAM
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238658
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
Ingram M; Wozniak EAL; Duvick L; Yang R; Bergmann P; Carson R; O'Callaghan B; Zoghbi HY; Henzler C; Orr HT
Neuron; 2016 Mar; 89(6):1194-1207. PubMed ID: 26948890
[TBL] [Abstract][Full Text] [Related]
11. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
Rousseaux MWC; Tschumperlin T; Lu HC; Lackey EP; Bondar VV; Wan YW; Tan Q; Adamski CJ; Friedrich J; Twaroski K; Chen W; Tolar J; Henzler C; Sharma A; Bajić A; Lin T; Duvick L; Liu Z; Sillitoe RV; Zoghbi HY; Orr HT
Neuron; 2018 Mar; 97(6):1235-1243.e5. PubMed ID: 29526553
[TBL] [Abstract][Full Text] [Related]
12. Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1.
Nitschke L; Coffin SL; Xhako E; El-Najjar DB; Orengo JP; Alcala E; Dai Y; Wan YW; Liu Z; Orr HT; Zoghbi HY
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554954
[TBL] [Abstract][Full Text] [Related]
13. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.
Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ
Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030
[TBL] [Abstract][Full Text] [Related]
14. Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1.
Shuvaev AN; Belozor OS; Mozhei OI; Shuvaev AN; Fritsler YV; Khilazheva ED; Mosyagina AI; Hirai H; Teschemacher AG; Kasparov S
Cells; 2022 Jul; 11(14):. PubMed ID: 35883691
[TBL] [Abstract][Full Text] [Related]
15. Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles.
Handler HP; Duvick L; Mitchell JS; Cvetanovic M; Reighard M; Soles A; Mather KB; Rainwater O; Serres S; Nichols-Meade T; Coffin SL; You Y; Ruis BL; O'Callaghan B; Henzler C; Zoghbi HY; Orr HT
Neuron; 2023 Feb; 111(4):493-507.e6. PubMed ID: 36577403
[TBL] [Abstract][Full Text] [Related]
16. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
Rosa JG; Hamel K; Soles A; Sheeler C; Borgenheimer E; Gilliat S; Sbrocco K; Ghanoum F; Handler HP; Forster C; Rainwater O; Cvetanovic M
Neurobiol Dis; 2023 Mar; 178():106023. PubMed ID: 36724861
[TBL] [Abstract][Full Text] [Related]
17. Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.
Edamakanti CR; Do J; Didonna A; Martina M; Opal P
J Clin Invest; 2018 Jun; 128(6):2252-2265. PubMed ID: 29533923
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice.
Qu W; Johnson A; Kim JH; Lukowicz A; Svedberg D; Cvetanovic M
J Neuroinflammation; 2017 May; 14(1):107. PubMed ID: 28545543
[TBL] [Abstract][Full Text] [Related]
19. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
20. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
Cvetanovic M; Ingram M; Orr H; Opal P
Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
